Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinton Transition Team Includes Tanden, Underscoring Rx Pricing Focus

Executive Summary

Center for American Progress President Neera Tanden has actively advocated Clinton’s position on prescription drug price controls over the past year.

Advertisement

Related Content

The Presidential Transition Teams: A Reunion of “Pfizer Pfriends”?
Clinton Vs. Trump: Three Scenarios For Biopharma
Drug Price Control Proposals Pared Down In Democrats’ Draft Platform
Clinton’s Drug Plan Embraces CER-Driven Pricing ‘Accountability’
Putting the Dough in the Donut Hole: Big Pharma Hits the Sweet Spot in the Reform Debate

Topics

Advertisement
UsernamePublicRestriction

Register

PS118979

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel